Transaction in Own Shares

Summary by AI ^BETAClose X

3i Group plc has purchased 701,317 ordinary shares for cancellation as part of its £750 million share buyback programme, incurring an aggregate cost of £15,038,879.18. The purchases, executed by Barclays Capital Securities Limited on the London Stock Exchange on May 14th and 15th, 2026, involved volumes ranging from 325,389 to 375,928 shares at prices between £18.3750 and £22.4200. Following these transactions, the total number of voting rights in the company is now 1,024,006,125.

Disclaimer*

3i Group PLC

18 May 2026

3i GROUP PLC

TRANSACTIONS IN OWN SHARES

3i Group plc (the "Company" or "3i") announces today that it has purchased for cancellation the following number of its ordinary shares of 73 19/22p each ("Shares") through Barclays Capital Securities Limited as part of the £750 million share buyback programme announced by 3i on 14 May 2026 (the "Programme"):

Date of transactions	Trading Venues	Aggregated volume (Shares)	Lowest Price per Share (£)	Highest Price per Share (£)	Volume weighted average price paid per share (£)
14/05/2026	London Stock Exchange	325,389	18.3750	22.0000	20.7998
15/05/2026	London Stock Exchange	375,928	21.6400	22.4200	22.0012

Following the above purchase and cancellation of the Shares, the total number of voting rights in the 3i will be 1,024,006,125 and this figure may be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. 3i does not hold any shares in treasury.

Since the commencement of this Programme, 3i has purchased 701,317 Shares for cancellation at an aggregate cost of £15,038,879.18 (excluding fees and taxes).

In accordance with Article 5(1)(b) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018, a full breakdown of the individual trades made by Barclays Capital Securities Limited on behalf of the Company as part of the Programme is detailed in the attached document.

http://www.rns-pdf.londonstockexchange.com/rns/6090E_1-2026-5-15.pdf

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END